GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » EV-to-FCF

Caplin Point Laboratories (BOM:524742) EV-to-FCF : (As of May. 25, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Caplin Point Laboratories's Enterprise Value is ₹90,560 Mil. Caplin Point Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil. Therefore, Caplin Point Laboratories's EV-to-FCF for today is .

The historical rank and industry rank for Caplin Point Laboratories's EV-to-FCF or its related term are showing as below:

BOM:524742' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 144.11
Current: 54.06

During the past 13 years, the highest EV-to-FCF of Caplin Point Laboratories was 144.11. The lowest was 0.00. And the median was 0.00.

BOM:524742's EV-to-FCF is ranked worse than
77.71% of 525 companies
in the Drug Manufacturers industry
Industry Median: 24.52 vs BOM:524742: 54.06

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Caplin Point Laboratories's stock price is ₹1302.35. Caplin Point Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹60.053. Therefore, Caplin Point Laboratories's PE Ratio for today is 21.69.


Caplin Point Laboratories EV-to-FCF Historical Data

The historical data trend for Caplin Point Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories EV-to-FCF Chart

Caplin Point Laboratories Annual Data
Trend Jun15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -61.65 13.94 18.55 49.25 53.31

Caplin Point Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.25 - - - 53.31

Competitive Comparison of Caplin Point Laboratories's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's EV-to-FCF falls into.



Caplin Point Laboratories EV-to-FCF Calculation

Caplin Point Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=90559.833/0
=

Caplin Point Laboratories's current Enterprise Value is ₹90,560 Mil.
Caplin Point Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caplin Point Laboratories  (BOM:524742) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Caplin Point Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1302.35/60.053
=21.69

Caplin Point Laboratories's share price for today is ₹1302.35.
Caplin Point Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹60.053.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Caplin Point Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories (BOM:524742) Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines